The Munich-based reinsurer is running a two-pronged playbook right now: returning cash to shareholders at a steady clip while simultaneously repositioning its portfolio toward a corner of the insurance market where pricing power still holds. The second tranche of its €2.25 billion buyback programme is now underway, with up to €1.449 billion earmarked for repurchases between 28 August and late January 2027. That timeline signals a deliberate, unhurried approach rather than a rushed deployment of capital.
The previous tranche wrapped up at the end of August, and the mechanics were telling. Munich Re scooped up 127,500 of its own shares on Xetra between 7 and 14 August, with a corrected regulatory filing revealing a 24,800-share purchase on 21 August at a weighted average price of €516.7181. The company had to issue a correction after a faulty date appeared in its eleventh interim notification — a minor administrative hiccup in an otherwise smoothly executed programme. The buyback’s cumulative effect on earnings per share is the real point for investors: fewer outstanding shares, a firmer floor under per-share metrics, and a clear signal that management views the stock as an attractive use of excess capital.
That capital discipline extends beyond buybacks into M&A. Roughly three weeks ago, Munich Re announced a majority stake in At-Bay, a US cyber insurer that pairs underwriting with active defence technology against cyberattacks — a hybrid model that traditional reinsurance alone cannot replicate. The price tag: around €494 million. The transaction is expected to close in the first quarter of 2027 and is aimed squarely at strengthening the company’s offering for small and midsize businesses.
The timing of the acquisition is no accident. Cyber is one of the fastest-growing insurance lines globally, but it behaves differently from natural catastrophe or property risk. The threat landscape shifts constantly, demanding underwriting models that can adapt in real time. At-Bay brings both premium volume and technological know-how that Munich Re can fold into its broader risk-assessment capabilities. The deal also arrives as the core reinsurance business faces headwinds: at the July renewal round, prices fell 5.5 percent and volumes dropped 9.1 percent. Back in April, Munich Re had already walked away from business at another renewal because quoted rates did not adequately compensate for risk. The cyber acquisition reads, in part, as a strategic answer to that pricing weakness.
Should investors sell immediately? Or is it worth buying Münchener Rück?
The numbers, for now, back up the strategy. First-half net profit came in at €3.925 billion, up from €3.178 billion in the same period last year. The solvency ratio stood at 304 percent at quarter-end, and return on equity hit 23 percent — comfortably above the long-term target of 18 percent. Revenue guidance for 2026 was trimmed from €64 billion to €62 billion about a month ago, yet the shares have still gained 1.0 percent since that revision. Investors appear to be weighting the confirmed profit target of €6.3 billion more heavily than the softer top-line figure.
The shareholder register remains active, too. Asset manager Amundi again crossed the 3 percent voting-rights threshold at the end of August, triggering a mandatory disclosure under Germany’s WpHG rules. Such threshold crossings are routine for a stock with this level of free float, but they do underscore that institutional investors are keeping the shares firmly on their radar.
At Friday’s close, the stock sat at €526.00, down 0.7 percent on the day. The weekly picture was brighter, with a 1.7 percent gain, and over the past 30 days the shares have advanced 1.6 percent — suggesting the latest dip reflects profit-taking rather than a fundamental reassessment. The At-Bay deal will not meaningfully move the balance sheet until 2027, so the current financial year remains the near-term focus. The question for investors is whether steady capital returns and selective expansion into niches like cyber can, over time, offset the softening pricing cycle in the traditional reinsurance market.
Ad
Münchener Rück Stock: Buy or Sell?! New Münchener Rück Analysis from September 6 delivers the answer:
The latest Münchener Rück figures speak for themselves: Urgent action needed for Münchener Rück investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 6.
Münchener Rück: Buy or sell? Read more here...
